In 2023, Italy's government expenditure on R&D in health was slightly under forecasted 2024 levels at approximately 1.19 Billion Euros. Projected figures suggest a steady growth trajectory, with expenditures increasing from 1.2 Billion Euros in 2024 to 1.27 Billion Euros by 2028. This represents a compound annual growth rate (CAGR) of 1.43% over the five-year period, with year-on-year growth figures between 1.64% and 0.81% annually. The gradual incline reflects a moderate and consistent investment increase in Italy’s health R&D sector.
Future trends to watch for include potential impacts of technological advancements, such as AI in healthcare, on R&D priorities. Additionally, shifts in government policy, economic conditions, and public health challenges can influence the pace of R&D investments. Observing these factors can provide insights into whether the current trajectory will persist or experience fluctuation.
